The IL-33-ILC2 pathway protects from amebic colitis
Md. Jashim Uddin(International University of Business Agriculture and Technology), William A. Petri(University of Virginia)
Cited by 1
Related Papers
IL-13 is a driver of COVID-19 severity
|JCI Insight|2021|159
IL-33 drives group 2 innate lymphoid cell-mediated protection during Clostridium difficile infection
|Nature Communications|2019|137
Diagnosis of Pathogenic Entamoeba histolytica Infection using a Stool ELISA Based on Monoclonal Antibodies to the Galactose-Specific Adhesin
|The Journal of Infectious Diseases|1993|123
Association of Serum Antibodies to Adherence Lectin with Invasive Amebiasis and Asymptomatic Infection with Pathogenic Entamoeba histolytica
|The Journal of Infectious Diseases|1990|108
Fecal Markers of Environmental Enteropathy and Subsequent Growth in Bangladeshi Children
|American Journal of Tropical Medicine and Hygiene|2016|102